
Currently out of the existing stock ratings of Tazeen Ahmad, 308 are a BUY (69.53%), 97 are a HOLD (21.9%), 38 are a SELL (8.58%).
Analyst Tazeen Ahmad, currently employed at BAML, has had 59.16% of price targets met with an average potential upside of 30.75%, reached in 176 days on average.
Tazeen Ahmad has documented 877 price targets and ratings displayed on 67 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on REGN, Regeneron Pharmaceuticals at 02-Nov-2026.
Analyst best performing recommendations are on SRZN (SURROZEN).
The best stock recommendation documented was for SRZN (SURROZEN) on 11/17/2022. The price target of $15 was fulfilled within 1 day with a profit of $1.65 (9.91%), with a performance score of 99.1.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 16-May-2025
$21
$3.89 (22.74%)
$25
4 days ago
(18-Nov-2026)
Hold Since 07-Mar-2025
$24
$6.89 (40.27%)
$28
9 days ago
(13-Nov-2026)
24/31 (77.42%)
$5.25 (28.00%)
206
Buy Since 22-Jun-2022
$38
$20.89 (122.09%)
$36
16 days ago
(06-Nov-2026)
13/23 (56.52%)
$16.77 (78.99%)
197
Buy Since 23-Jun-2025
$38
$20.89 (122.09%)
$36
17 days ago
(05-Nov-2026)
1/11 (9.09%)
$16.76 (78.91%)
173
Buy Since 28-Feb-2024
$35
$17.89 (104.56%)
$35
1 months 3 days ago
(19-Oct-2026)
9/17 (52.94%)
$15.2 (76.77%)
393
Stocks Tazeen Ahmad covered previously. Scores are shown for active stocks only.
The record of these past calls is part of the data set at anachart.store.
Which stock is Tazeen Ahmad most bullish on?
Which stock is Tazeen Ahmad most reserved on?
What Year was the first public recommendation made by Tazeen Ahmad?